Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Blocking certain brain processes reduces mating behavior in female rats.

Trichothiodystrophy hair is structurally abnormal with protein and organization issues.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Activating TRPV3 channels stops hair growth by killing hair follicle cells.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

The MtAnn3 gene affects root hair growth and is influenced by cytokinin.

Ritlecitinib can reduce inflammation and help hair regrow in Alopecia Areata.

The compound from Rhododendron mucronulatum roots may help treat male pattern hair loss.

Thyroid hormone and epidermal growth factor affect hair angle, tooth eruption, and ear development in rats.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Ritlecitinib was generally well tolerated in children with alopecia areata.

TCDD reduces EGF receptor activity and causes various developmental changes in animals.

Acetyl tetrapeptide-3 was successfully made for use in hair loss treatments.

CTHRC1 is essential for healing and preventing heart rupture after a heart attack.

Stat3 affects skin cancer development by altering keratinocyte stem cell behavior.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

C.I. Acid Orange 3 caused cancer in female rats but not in male rats or mice.

Trichothiodystrophy is a rare genetic disorder causing hair issues and sometimes linked to DNA repair defects.

Overexpressing ATF3 in mice's epithelial cells may lead to oral cancer.

SCUBE3 is a potential target for cancer and alopecia treatment but is challenging to target due to its varied roles.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.